TrialBMC clinical pharmacology2011

Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies.

Helen Tomkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.